Family facts
IDVParent PIIDSPE2DB22D2206
Also listed asSPE2DB-22-D-2206
AgencyDla Troop Support
Awarding officeDla Troop Support
Awarding agencyDepartment of Defense (DOD)
Period endOct 21, 2025
IDV obligated$52.1M
Child awards347
Places of performance
StatesPA
Distinctive task orders
12SPE2DB25FKD78 — 4569634075!REVLIMID 10 MG CAPSULE 100S
Amerisourcebergen Drug Corp. · $1.3M · PoP Oct 20, 2025
SPE2DB25FKE04 — 4569625519!OCREVUS 300 MG/10 ML VIAL 10ML
Amerisourcebergen Drug Corp. · $1.1M · PoP Oct 21, 2025
SPE2DB25FKE56 — 4569627990!OCREVUS 300 MG/10 ML VIAL 10ML
Amerisourcebergen Drug Corp. · $998K · PoP Oct 21, 2025
SPE2DB22FER08 — 4558321058!REVLIMID 10 MG CAPSULE 100S
Amerisourcebergen Drug Corp. · $428K · PoP Sep 23, 2022
SPE2DB25FEJ82 — 4566533172!REVLIMID 5 MG CAPSULE 100S
Amerisourcebergen Drug Corp. · $388K · PoP Dec 16, 2024
SPE2DB23FKE92 — 4562106624!REVLIMID 10 MG CAPSULE 100S
Amerisourcebergen Drug Corp. · $373K · PoP Sep 29, 2023
SPE2DB24FKB19 — 4565638098!REVLIMID 10 MG CAPSULE 100S
Amerisourcebergen Drug Corp. · $357K · PoP Sep 20, 2024
SPE2DB24FJT23 — 4565432053!REVLIMID 10 MG CAPSULE 100S
Amerisourcebergen Drug Corp. · $357K · PoP Sep 3, 2024
SPE2DB24FKB21 — 4565638099!REVLIMID 25 MG CAPSULE 100S
Amerisourcebergen Drug Corp. · $357K · PoP Sep 20, 2024
SPE2DB22FEX04 — 4558513589!NORVASC 10 MG TABLET 90S
Amerisourcebergen Drug Corp. · $347K · PoP Sep 20, 2022
SPE2DB23FHC40 — 4560903086!REVLIMID 10 MG CAPSULE 100S
Amerisourcebergen Drug Corp. · $311K · PoP Jun 1, 2023
SPE2DB24FJX22 — 4565548603!PEDMARK 12.5 GRAM/100 ML VIAL 100ML
Amerisourcebergen Drug Corp. · $305K · PoP Sep 12, 2024
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
Data as of · refreshed monthly